| Nonyerem Rosemary Eneje, DNP | |
|
2788 Murfreesboro Pike, Antioch, TN 37013-2004 | |
| (615) 367-2211 | |
| Not Available |
| Full Name | Nonyerem Rosemary Eneje |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 2788 Murfreesboro Pike, Antioch, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780980623 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mindful Therapy Group, P.c. | 4981872561 | 198 |
News Archive
ImmunoGen, Inc. today announced that it has initiated Phase II testing of its IMGN901 product candidate for first-line treatment of SCLC.
Body weight in young adulthood and diet appeared to be associated with the risk for non-Hodgkin lymphoma, according to results presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.
New research reveals that a hormone best known for stimulating the production of red blood cells can modulate the immune response. The study, published by Cell Press in the January 27th issue of the journal Immunity, finds that erythropoietin has contrasting influences on infectious and inflammatory diseases and may be useful in the design of new therapeutic strategies.
Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.
› Verified 9 days ago
| Entity Name | Mindful Therapy Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316238678 PECOS PAC ID: 4981872561 Enrollment ID: O20110726000730 |
News Archive
ImmunoGen, Inc. today announced that it has initiated Phase II testing of its IMGN901 product candidate for first-line treatment of SCLC.
Body weight in young adulthood and diet appeared to be associated with the risk for non-Hodgkin lymphoma, according to results presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.
New research reveals that a hormone best known for stimulating the production of red blood cells can modulate the immune response. The study, published by Cell Press in the January 27th issue of the journal Immunity, finds that erythropoietin has contrasting influences on infectious and inflammatory diseases and may be useful in the design of new therapeutic strategies.
Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nonyerem Rosemary Eneje, DNP 2788 Murfreesboro Pike, Antioch, TN 37013-2004 Ph: (615) 367-2211 | Nonyerem Rosemary Eneje, DNP 2788 Murfreesboro Pike, Antioch, TN 37013-2004 Ph: (615) 367-2211 |
News Archive
ImmunoGen, Inc. today announced that it has initiated Phase II testing of its IMGN901 product candidate for first-line treatment of SCLC.
Body weight in young adulthood and diet appeared to be associated with the risk for non-Hodgkin lymphoma, according to results presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.
New research reveals that a hormone best known for stimulating the production of red blood cells can modulate the immune response. The study, published by Cell Press in the January 27th issue of the journal Immunity, finds that erythropoietin has contrasting influences on infectious and inflammatory diseases and may be useful in the design of new therapeutic strategies.
Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.
› Verified 9 days ago
Mrs. Rachel Benz Grace, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4200 Murfreesboro Pike, Antioch, TN 37013 Phone: 615-501-3500 | |
Jennifer Friley, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4676 Chutney Dr, Antioch, TN 37013 Phone: 615-554-3879 | |
Mrs. Joelle M Krizner, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5801 Crossings Blvd, Antioch, TN 37013 Phone: 615-941-8501 Fax: 615-941-8102 | |
Candius G Loggins, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5801 Crossings Blvd, Antioch, TN 37013 Phone: 615-851-9401 | |
Miss Natsai Laurah Zhou, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2929 Old Franklin Rd, # 809, Antioch, TN 37013 Phone: 615-243-0776 | |
Michelle Aubrie Feneck, RN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2788 Murfreesboro Pike, Antioch, TN 37013 Phone: 714-329-7594 | |
Mrs. Mendy A Hicks, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5801 Crossings Blvd, Antioch, TN 37013 Phone: 615-941-8501 Fax: 615-941-8502 |